The RaDAR team is thrilled to announce an exciting expansion of our consortium with the addition of three esteemed institutions: Consorci de Salut i Social de Catalunya (CSC), Hospital del Mar (HMAR), and Laboratori de Referència de Catalunya, SA (LRC). This collaboration marks a significant milestone in our ongoing efforts to advance patient and public involvement (PPI) in healthcare innovation and research.
The integration of these new members enhances the depth and breadth of our consortium. Together with the Catalan Institute of Oncology (ICO), their participation brings two fresh opportunities for funding under the RaDAR project.
In addition to welcoming these new partners, we are gearing up for an exciting development this December 2024: the launch of a new tender for ICO and one for LRC. This initiative aims to catalyze collaboration across sectors, enabling innovative solutions against the threat of AMR.
We are confident that the new partners will further strengthen RaDAR’s mission to promote excellence in healthcare research through inclusive and collaborative initiatives.
Stay tuned for further updates on the tender process and how you can get involved. Let’s continue to work together to make a meaningful impact in the healthcare landscape. Make sure to check out the Call for Tenders page for all major updates: https://radar-ppi.com/procurement/radar-call-for-tenders/.
